← Eichor
Condition: Chronic Bronchitis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Chronic Bronchitis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Long-term Extension Study of PCI-32765 (Ibrutinib)
Phase 3 · 175 location(s) · Janssen Research & Development, LLC · NCT01804686Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease
NA · 1 location(s) · MGH Institute of Health Professions · NCT06304207Boston Early-Onset Chronic Obstructive Pulmonary Disease (COPD) Study
Phase N/A · 1 location(s) · Brigham and Women's Hospital · NCT01177618Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Phase 2 · 24 location(s) · Novartis Pharmaceuticals · NCT07354074Quebec Low Back Pain Study: Core Dataset
Phase N/A · 1 location(s) · Laval University · NCT04791891Axatilimab for Sclerotic Chronic Graft-versus-Host Disease
Phase 2 · 3 location(s) · Fred Hutchinson Cancer Center · NCT07011810Pegmolesatide Treatment for Anemia in Patients Undergoing Long-term Dialysis
Phase 4 · 1 location(s) · Chinese PLA General Hospital · NCT07045155Laparoendoscopic Rendezvous for Concomitant Gall Bladder Stones and Common Bile Duct Stones
NA · 1 location(s) · Minia University · NCT07008170LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.
Phase 2 · 1 location(s) · Steven Hays, MD · NCT06018766A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Phase 2 · 121 location(s) · Syndax Pharmaceuticals · NCT04710576A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Di
Phase 2 · 41 location(s) · Incyte Corporation · NCT07124078A Prospective Study of Madecassoside Tablets in Sclerotic Chronic Graft-versus-Host Disease After Allo-HSCT
Phase 2 · 1 location(s) · WeiShi · NCT07606703An Efficacy and Safety Study of DFL24498 in the Treatment of AKC
Phase 3 · 19 location(s) · Dompé Farmaceutici S.p.A · NCT07395232Nintedanib in Patients With Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem Cell Transplantation
Phase 2 · 3 location(s) · University Hospital, Basel, Switzerland · NCT03805477Efficacy and Safety of FEXUCLUE Tab. In Patients With Acute or Chronic Gastritis
Phase N/A · 1 location(s) · Daewoong Pharmaceutical Co. LTD. · NCT06948487PERSONOLOGICAL STRUCTURE, COGNITIVE FUNCTIONS AND CENTRAL SENSITIZATION IN HEADACHE
Phase N/A · 1 location(s) · IRCCS Centro Neurolesi Bonino Pulejo · NCT07268768Evaluation of the Efficacy of Azithromycin in Idiopathic Purulent Oedematous Sinusitis in Adults
Phase 3 · 13 location(s) · Centre Hospitalier Intercommunal Creteil · NCT05157685Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
Phase 1 · 5 location(s) · Tr1X, Inc. · NCT06462365Non-Invasive Interventions for Respiratory Recovery in Chronic Spinal Cord Injury
NA · 1 location(s) · Thomas Jefferson University · NCT07135583Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression
Phase 2 · 1 location(s) · VA Office of Research and Development · NCT06419439Evaluation of Belumosudil Whole Tablets vs. Crushed Tablets Pharmacokinetics in Patients Suffering From Chronic GvHD
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT07127926Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial
NA · 2 location(s) · Dana-Farber Cancer Institute · NCT05236062Mobile Health Self-Management and Support System for Chronic and Complex Health Conditions
NA · 1 location(s) · University of Pittsburgh · NCT02592291A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease
Phase 2 · 12 location(s) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06300320Tissue Immune Landscape of Graft Versus Host Disease After Allogeneic Stem Cell Transplantation (TIL-GVHD)
NA · 1 location(s) · University Hospital, Bordeaux · NCT06247150HALP Score, Blood-Based Inflammatory Indices, and Salivary MMP-8 in Periodontal Disease and Healing After Non-Surgical T
Phase N/A · 1 location(s) · Ömer Faruk Okumuş · NCT07312045Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
Phase N/A · 36 location(s) · Freenome Holdings Inc. · NCT06122077Ruxolitinib Plus Fostamatinib for Steroid Refractory cGvHD
Phase 1 · 1 location(s) · Stefanie Sarantopoulos, MD, PhD. · NCT06233110Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury
Phase 2 · 2 location(s) · Hope Biosciences LLC · NCT05951777Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
Phase 2 · 12 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06476132
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.